Equities

OptiBiotix Health PLC

OPTI:LSE

OptiBiotix Health PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)17.25
  • Today's Change-0.50 / -2.82%
  • Shares traded105.48k
  • 1 Year change72.50%
  • Beta1.7862
Data delayed at least 20 minutes, as of Apr 29 2024 14:42 BST.
More ▼

Profile data is unavailable for this security.

About the company

OptiBiotix Health Plc is a United Kingdom-based life sciences company. The Company is primarily engaged in identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry segment. Its technology platforms include OcptiBiome, OptiScreen and OptiBiotic. Its OptiBiome technology platform that screens identifies and/or develops microbiome modulators, which can be used in formulations to prevent, manage and a range of chronic lifestyle diseases. The OptiScreen pharmaceutical screening platform to identify microbial metabolic pathways that interact with human pathways to improve health. The OptiBiotic platform generates oligosaccharides and screens them for their ability to modulate specific microbial genera or species and their microbial end products (short chain fatty acids, such as acetate, propionate, butyrate) and physical properties (sweetness). Its products include SlimBiome, SweetBiotix, CholBiomeX3, SlimBiome Medical and WellBiome.

  • Revenue in GBP (TTM)689.10k
  • Net income in GBP-13.17m
  • Incorporated2006
  • Employees3.00
  • Location
    OptiBiotix Health PLCInnovation Centre, Innovation WayHESLINGTON Y010 5DGUnited KingdomGBR
  • Phone+44 20 7933 8780
  • Websitehttp://www.optibiotix.com
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Chill Brands Group PLC146.62k-3.64m10.13m2.0010.13m2.00
Shield Therapeutics PLC7.21m-46.89m10.56m28.0010.56m28.00
Kanabo Group PLC813.00k-4.66m10.75m20.0010.75m20.00
Abingdon Health PLC5.34m-2.24m12.17m82.0012.17m82.00
Proteome Sciences plc5.03m-2.44m12.25m35.0012.25m35.00
Genincode PLC1.72m-6.73m12.83m28.0012.83m28.00
Incanthera PLC0.00-1.48m12.91m8.0012.91m8.00
Synairgen plc0.00-9.99m13.07m30.0013.07m30.00
Provexis plc598.08k-496.59k13.58m2.0013.58m2.00
Destiny Pharma PLC0.00-5.97m15.49m20.0015.49m20.00
Oncimmune Holdings PLC1.15m-6.15m17.05m56.0017.05m56.00
OptiBiotix Health PLC689.10k-13.17m17.38m3.0017.38m3.00
Verici DX PLC15.21k-8.98m17.62m14.0017.62m14.00
LungLife AI Inc36.83k-4.33m17.82m19.0017.82m19.00
Skinbiotherapeutics PLC161.65k-2.88m18.54m11.0018.54m11.00
Hemogenyx Pharmaceuticals PLC0.00-6.69m22.14m17.0022.14m17.00
Data as of Apr 29 2024. Currency figures normalised to OptiBiotix Health PLC's reporting currency: UK Pound GBX

Institutional shareholders

23.38%Per cent of shares held by top holders
HolderShares% Held
KW Investment Management Ltd.as of 01 Sep 202310.23m11.22%
Hargreaves Lansdown Asset Management Ltd.as of 01 Sep 20234.68m5.13%
Jarvis Investment Management Ltd.as of 01 Sep 20231.71m1.87%
IG Markets Ltd.as of 01 Sep 20231.61m1.76%
HSBC Global Asset Management (UK) Ltd.as of 01 Sep 20231.53m1.67%
Rathbones Investment Management Ltd.as of 01 Sep 2023524.00k0.58%
iDealing.com Ltd.as of 01 Sep 2023386.00k0.42%
HSBC Bank Plc (Market-Maker)as of 01 Sep 2023348.00k0.38%
Evelyn Partners Investment Management Services Ltd.as of 01 Sep 2023156.00k0.17%
Evelyn Partners Investment Management LLPas of 01 Sep 2023153.00k0.17%
More ▼
Data from 31 Dec 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.